http://www.mesothelioma-line.com/articles Journal Articles on Mesothelioma: Cancer Information for Patients and Families Sat, 28 Nov 2009 16:43:42 +0000 http://backend.userland.com/rss092 en Molecular Diagnosis & Therapy. 2008;12(6):375-90. doi: 10.2165/1250444-200812060-00004. [Link] Greillier L, Baas P, Welch JJ, Hasan B, Passioukov A. European Organisation for Research and Treatment of Cancer (EORTC), Headquarters, Brussels, Belgium. laurent.greillier@mail.ap-hm.fr Abstract Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor prognosis, whose main etiology is exposure to asbestos fibers. The ... http://www.mesothelioma-line.com/articles/2009/11/28/biomarkers-for-malignant-pleural-mesothelioma-current-status/ Annals of Surgical Oncology. 2009 Feb;16(2):334-44. Epub 2008 Dec 3. [Link] Miao N, Pingpank JF, Alexander HR, Royal R, Steinberg SM, Quezado MM, Beresnev T, Quezado ZM. Department of Anesthesia and Surgical Services, National Institutes of Health Clinical Center, National Institutes of Health, 10 Center Drive, MSC-1512, Building 10, Room 2C624, Bethesda, ... http://www.mesothelioma-line.com/articles/2008/12/04/cytoreductive-surgery-and-continuous-hyperthermic-peritoneal-perfusion-in-patients-with-mesothelioma-and-peritoneal-carcinomatosis-hemodynamic-metabolic-and-anesthetic-considerations/ Cancer Research. 2008 Dec 1;68(23):9678-85. [Link] Graziani I, Eliasz S, De Marco MA, Chen Y, Pass HI, De May RM, Strack PR, Miele L, Bocchetta M. Department of Pathology and Oncology Institute, Loyola University Chicago, Cancer Center, Maywood, Illinois 60153, USA. Abstract Malignant mesothelioma (MM) is a cancer of the lining ... http://www.mesothelioma-line.com/articles/2008/12/03/opposite-effects-of-notch-1-and-notch-2-on-mesothelioma-cell-survival-under-hypoxia-are-exerted-through-the-akt-pathway/ Lung Cancer. 2009 May;64(2):211-8. Epub 2008 Nov 29. [Link] Carteni G, Manegold C, Garcia GM, Siena S, Zielinski CC, Amadori D, Liu Y, Blatter J, Visseren-Grul C, Stahel R. Cardarelli Hospital, Medical Oncology, Via Cardarelli 9, 80100 Naples, Italy. giacomo.carteni@ospedalecardarelli.it Abstract Aim: Peritoneal mesothelioma (PM) has rarely been studied. The Expanded Access ... http://www.mesothelioma-line.com/articles/2008/12/02/malignant-peritoneal-mesothelioma-results-from-the-international-expanded-access-program-using-pemetrexed-alone-or-in-combination-with-a-platinum-agent/ Internal Medicine. 2008;47(23):2053-6. Epub 2008 Dec 1. [Link] Kimura T, Koyama K, Kudoh S, Kawabe J, Yoshimura N, Mitsuoka S, Shiomi S, Hirata K. Department of Respiratory Medicine, Osaka City University, Osaka. kimutats@med.osaka-cu.ac.jp Abstract We report a 56-year-old man who underwent monitoring of the response to chemotherapy of malignant pleural mesothelioma (MPM). 8F-fluoro-2-deoxy-D-glucose ... http://www.mesothelioma-line.com/articles/2008/12/02/monitoring-of-chemotherapy-response-in-malignant-pleural-mesothelioma-using-fluorodeoxyglucose-positron-emission-tomography/ Anticancer Research. 2008 Sep-Oct;28(5B):2997-3006. [Link] Raica M, Cimpean AM, Ribatti D. Department of Histology and Cytology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania. Abstract In the last decade, much data has been generated concerning the molecular mechanisms of lymphangiogenesis and its significance in pathological conditions. This was mainly due to the discovery ... http://www.mesothelioma-line.com/articles/2008/11/27/the-role-of-podoplanin-in-tumor-progression-and-metastasis/ Journal of the Egyptian National Cancer Institute. 2007 Jun;19(2):147-57. [Link] Ismail HM, Moneer M, El-Baradie M, Khorshid O, Touny A. The Department of Pathology , National Cancer Institute, Cairo University. Hodanci@hotmail.com Abstract Background: The aim of the study was to verify the frequency of the immunohistochemical overexpression of her-2/neu and p53 in gastric carcinoma ... http://www.mesothelioma-line.com/articles/2008/11/27/clinicopathologic-and-prognostic-significance-of-overexpression-of-her-2neu-and-p53-oncoproteins-in-gastric-carcinoma-using-tissue-microarray/ Revue des Maladies Respiratoires. 2008 Oct;25(8 Pt 2):3S18-31. [Link] Pairon JC, Andujar P, Matrat M, Ameille J. INSERM Unité 841, Créteil, France. JC.Pairon@chicreteil.fr Abstract Lung cancer and pleural mesothelioma are the most common occupational cancers. Recent epidemiological studies have estimated that the fraction attributable to occupational factors varies from 13 to 29% for lung cancer ... http://www.mesothelioma-line.com/articles/2008/11/26/etiology-epidemiology-biology-occupational-respiratory-cancers/ Revue des Maladies Respiratoires. 2008 Oct;25(8 Pt 2):3S183-90. [Link] Scherpereel A, Grigoriu BD, Astoul P. Service de Pneumologie et Oncologie Thoracique, Hôpital Calmette, CHRU de Lille, Lille, France. a-scherpereel@chru-lille.fr Abstract Malignant pleural mesothelioma (MPM) is a serious issue worldwide because of its increasing incidence and poor prognosis despite real recent improvements in the disease ... http://www.mesothelioma-line.com/articles/2008/11/26/malignant-pleural-mesothelioma-biology-and-diagnosis/ Revue des Maladies Respiratoires. 2008 Oct;25(8 Pt 2):3S191-5. [Link] Berghmans T. Département des Soins Intensifs et Oncologie Thoracique, Institut Jules-Bordet (Centre des Tumeurs de l'Université Libre de Bruxelles), 1 Rue Héger-Bordet, Brussels, Belgium. thierry.berghmanns@bordet.be Abstract Malignant pleural mesothelioma is a rare tumour of poor prognosis. Available therapeutics have restricted efficacy. Pleuro-pneumonectomy is the only ... http://www.mesothelioma-line.com/articles/2008/11/26/other-thoracic-cancers-mesothelioma-treatment/